| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.33 | 0.05 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.28 | 0.05 |